Russell Investments Group’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
Other funds holding AERI
DM
JG
WIC
NAM
RHJA
Russell Investments Group's AERI Position: Q3 2022 in Review
Russell Investments Group sold out of Aerie Pharmaceuticals (AERI) in Q3 2022, closing a stake of 56,621 shares — an estimated $424K sold.
Russell Investments Group first reported a position in AERI in Q4 2016 and held it in 17 quarters. The position peaked at $25.3M in Q3 2018. 156 funds tracked by Wall St. Rank hold AERI as of Q3 2022.
- Russell Investments Group reported no remaining Aerie Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
- Russell Investments Group sold 56,621 Aerie Pharmaceuticals shares in Q3 2022, an estimated $424K.
- Russell Investments Group first reported a position in Aerie Pharmaceuticals in Q4 2016 and held it in 17 quarters.
- Russell Investments Group's Aerie Pharmaceuticals position peaked at $25.3M in Q3 2018.
- 156 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2022.
Based on Russell Investments Group's 13F filing for Q3 2022, filed 4 Nov 2022.